Molly Henderson
Finanzdirektor/CFO bei PHATHOM PHARMACEUTICALS, INC.
Vermögen: 884 283 $ am 30.04.2024
Aktive Positionen von Molly Henderson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PHATHOM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 05.04.2022 | - |
Finanzdirektor/CFO | 05.04.2022 | - |
Karriereverlauf von Molly Henderson
Ehemalige bekannte Positionen von Molly Henderson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CALLIDITAS THERAPEUTICS AB | Direktor/Vorstandsmitglied | 25.06.2020 | 30.05.2023 |
Independent Dir/Board Member | - | 30.05.2023 | |
UROGEN PHARMA LTD. | Comptroller/Controller/Auditor | 01.10.2020 | 25.03.2022 |
Finanzdirektor/CFO | 01.10.2020 | 25.03.2022 | |
AYALA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 06.06.2018 | 25.09.2020 |
IOVANCE BIOTHERAPEUTICS, INC. | Finanzdirektor/CFO | 08.06.2015 | 01.08.2016 |
Investor Relations Kontakt | 08.06.2015 | 01.08.2016 | |
VIRTUALSCOPICS INC | Finanzdirektor/CFO | 01.05.2003 | 31.08.2013 |
Unternehmenssekretär | 02.11.2009 | 31.08.2013 | |
ULTRALIFE CORPORATION | Comptroller/Controller/Auditor | 01.08.2000 | 01.08.2002 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | - | - |
Ausbildung von Molly Henderson
State University of New York at Buffalo | Graduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Ungarn | 2 |
Schweden | 2 |
Operativ
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 4 |
Corporate Secretary | 1 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Producer Manufacturing | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
ULTRALIFE CORPORATION | Producer Manufacturing |
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
CALLIDITAS THERAPEUTICS AB | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
PHATHOM PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
VirtualScopics, Inc.
VirtualScopics, Inc. Miscellaneous Commercial ServicesCommercial Services VirtualScopics, Inc. provides quantitative imaging solutions currently serving the pharmaceutical, biotechnology and medical device industries. It provides image analysis software tools and applications which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. The company's therapeutic area expertise includes oncology, rheumatoid arthritis, osteoarthritis, neurology, cardiovascular, muscle and fat measurements and COPD studies utilizing MRI, PET, CT, Ultrasound and X-Ray imaging modalities. VirtualScopics was founded by Saara Totterman, Kevin J. Parker, Jose Tamez-Pena and Edward Ashton in July 2000 and is headquartered in Rochester, NY. | Commercial Services |
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
- Börse
- Insiders
- Molly Henderson
- Erfahrung